FDA Grants Orphan Drug Designation to DIAG723 for Treatment of HHT
New Hope on the Horizon: Promising Developments in Hereditary Hemorrhagic Telangiectasia (HHT) Treatment For those living with Hereditary Hemorrhagic Telangiectasia (HHT), a rare genetic disorder, managing its effects can be a constant challenge. Characterized by the formation of abnormal blood vessels, HHT often leads to recurrent bleeding and complications like anemia. But recent advancements offer … Read more